Castelnau Le Lez, France Clinical Trials

A listing of Castelnau Le Lez, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 704 clinical trials
Behavior of the Upper Cervical Spine in Rugby Players

Rugby players are often exposed to destabilisation of the upper cervical spine.This kind of trauma may lead to dramatic injuries, due to lesion of spinal cord. CerviStab is a device which evaluate the bio-mechanical and neuromuscular behavior of the upper cervical spine in rugby situation. The aim of this study, …

Montpellier university Hospital
 (1.9 away) Contact site
  • 22 Mar, 2021
  • 1 location
A Phase III Randomized Blind Double Dummy Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion

The aim of the THEIA study is to determine if Alteplase administrated within 4.5 hours improve visual deficit due to acute CRAO with a good safety profile.

CHU de Montpellier
 (7.5 away) Contact site
  • 27 Jan, 2021
  • +26 other locations
Sophrology and Congenital Heart Disease

The SOPHRO-CARE trial aims to measure the impact of sophrology on exercise capacity of adolescents and young adults with congenital heart disease. Investigator hypothesized that a series of group sessions of sophrology may improve the exercise capacity, in this population.

CHU Arnaud de Villeneuve
 (1.9 away) Contact site
  • 26 Jan, 2021
  • 1 location
Development of Clinical and Biological Database in Colorectal Cancer

Creation of circulating cancer cell-lines and caracterisation of these cell-lines which will be collected before any treatment in patients with metastatic colon adenocarcinoma

metastatic colorectal cancer
ICM Val d'Aurelle
 (1.9 away) Contact site
  • 26 Jan, 2021
  • 1 location
Decompressive Craniectomy for Severe Traumatic Brain Injury in Children With Refractory Intracranial Hypertension

Severe traumatic brain injury (TBI) is the leading cause of mortality and severe disability in the pediatric population. The prognosis of these patients depends on the severity of the initial lesions but also on the effectiveness of the therapies used to prevent or at least limit secondary lesions mainly intracranial …

H pital Guy de Chauliac
 (1.9 away) Contact site
  • 14 May, 2021
  • +16 other locations
Interval Training in Heart Failure

Heart failure (HF) is currently considered a common pathology, with 15 million adults in Europe and 26 million worldwide. The American Heart Association (AHA) estimates that their number will increase by 25% by 2030. In France, HF affects more than one million people. Because of the repeated hospitalizations of this …

cardiac rehabilitation
systolic heart failure
CHU Montpellier
 (7.5 away) Contact site
  • 20 Jul, 2021
  • 1 location
Excision and Reconstruction of the Natal Cleft With a Parasacral Perforator Flap Versus Open Excision With Secondary Healing in the Management of Sacrococcygeal Pilonidal Disease.

Chronic sacrococcygeal pilonidal disease is a common acquired condition associated with hirsutism that predominantly affects young male patients. Morbidity from this disease results in pain, embarrassment and loss of normal activities, causing absenteeism from work and school. Various surgical procedures have been described for the treatment of both primary and …

University Hospital
 (7.5 away) Contact site
  • 26 Jan, 2021
  • 1 location
LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy

Cytotoxic chemotherapy is usually scaled to the body surface area (BSA), and is currently not adjusted to the body proportions of lean and fat (i.e. body composition) of individual patients. Patients with low muscle mass behave like patients "overdosed" with chemotherapy resulted in dose-limiting toxicities (e.g. dose reductions, treatment delays …

Institut regional du Cancer - Val d Aurelle
 (3.0 away) Contact site
  • 24 Jan, 2021
  • 1 location
Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients

National trial, multicenter, randomized, phase II assessing FOLFIRINOX + Panitumumab versus mFOLFOX6 + Panitumumab in metastatic colorectal cancer patients selected by RAS and B-RAF status from circulating DNA analysis. Evaluation of complete response rate on treatment combining FOLFIRINOX and panitumumab.

measurable disease
adenocarcinoma of colon
ICM Val D'Aurelle
 (1.9 away) Contact site
  • 02 Aug, 2021
  • +8 other locations
Effect of Intratumoral Injection of Gene Therapy for Locally Advanced Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is the fifth leading cause of cancer-related death in Western countries, and its incidence has increased over the last 40 years. Curative surgery to manage PDAC is possible in only a fraction of patients; indeed, a vast majority (85%) of patients is diagnosed with locally advanced …

ductal adenocarcinoma
Institut r gional du Cancer
 (1.9 away) Contact site
  • 24 Jan, 2021
  • +9 other locations